Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
October 25, 2021COSTEM: maintenance therapies for FLT3+ AML8 minutesPlayThe FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately 30% of patients with acute myeloid leukemia (AML) and......moreShareView all episodesBy VJHemOnc4.522 ratingsOctober 25, 2021COSTEM: maintenance therapies for FLT3+ AML8 minutesPlayThe FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately 30% of patients with acute myeloid leukemia (AML) and......more
The FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately 30% of patients with acute myeloid leukemia (AML) and...
October 25, 2021COSTEM: maintenance therapies for FLT3+ AML8 minutesPlayThe FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately 30% of patients with acute myeloid leukemia (AML) and......more
The FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately 30% of patients with acute myeloid leukemia (AML) and...